CIK 0001348362
- Non-accelerated filer
- Smaller reporting company
Lexaria Bioscience Corp.
Sign in to watch- Ticker
- LEXX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Aug 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 202000871
- Phone
- +1 250-765-6424
- Business address
- 100 - 740 MCCURDY ROAD, KELOWNA, British Columbia, Canada, V1X 2P7
- Former names
- Lexaria Corp., LEXARIA CORP.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-08-17 | DOCHERTY JOHN MARTIN President | Returned to the company | −500,000 | $0.17 | $85K | 130,000 |
| 2015-08-17 | DOCHERTY JOHN MARTIN President | Purchase | +420,000 | $0.20 | $84K | 550,000 |
| 2015-08-12 | BUNKA CHRISTOPHER CEO | Purchase | +30,000 | $0.18 | $5K | 5,077,930 |
| 2015-08-11 | BUNKA CHRISTOPHER CEO | Purchase | +10,000 | $0.18 | $2K | 5,047,930 |
| 2015-08-10 | BUNKA CHRISTOPHER CEO | Purchase | +5,000 | $0.18 | $875 | 4,940,930 |
| 2015-08-10 | BUNKA CHRISTOPHER CEO | Purchase | +10,000 | $0.18 | $2K | 4,950,930 |
| 2015-08-10 | BUNKA CHRISTOPHER CEO | Purchase | +1,000 | $0.18 | $175 | 4,951,930 |
| 2015-08-10 | BUNKA CHRISTOPHER CEO | Purchase | +5,000 | $0.17 | $863 | 4,956,930 |
| 2015-08-10 | BUNKA CHRISTOPHER CEO | Purchase | +25,000 | $0.18 | $4K | 4,981,930 |
| 2015-08-10 | BUNKA CHRISTOPHER CEO | Purchase | +45,000 | $0.18 | $8K | 5,026,930 |
| 2015-08-10 | BUNKA CHRISTOPHER CEO | Purchase | +11,000 | $0.17 | $2K | 5,037,930 |
| 2014-12-23 | Baxter Nicholas W Director | Grant or award · Stock Options | +10,000 | $0.10 | $1K | 275,000 |
| 2014-12-23 | Bhullar Baljinder CFO | Grant or award · Stock Options | +50,000 | $0.10 | $5K | 852,500 |
| 2013-06-18 | Bhullar Baljinder CFO | Grant or award · Stock Options | +17,500 | $0.09 | $2K | 302,500 |
| 2011-07-11 | Baxter Nicholas W Director | Grant or award · Stock Options | +15,000 | $0.32 | $5K | 165,000 |
| 2011-07-11 | Bhullar Baljinder CFO | Grant or award · Stock Options | +10,000 | $0.32 | $3K | 110,000 |
Page 21 of 21 · 416 trades